3i to acquire Active Pharmaceutical Ingredients for $395m
3i is to back the buyout of Active Pharmaceutical Ingredients, an international developer and supplier of specialist active pharmaceutical ingredients and a division of New York Stock Exchange-listed Alpharma, for around $395m (€267m).
Oslo-based